Reconstitution of the cellular immune response after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin's lymphoma

British Journal of Haematology

Volumn 108, Issue 2, 2000, Pages 415-423

  Nolte, Annette ^a,b,d   Buhmann, Raymund ^a,b   Emmerich, Bertold ^b   Schendel, Dolores ^c   Hallek, Michael ^a,b  

^a Genzentrum   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cytotoxic T lymphocytes; Epstein Barr virus; Immune reconstitution; Non Hodgkin's lymphoma; Peripheral blood stem cell transplantation

Indexed keywords

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; EPSTEIN BARR VIRUS; FEMALE; HUMAN; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNITY, CELLULAR; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION IMMUNOLOGY;

EID: 0034058564     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01841.x     Document Type: Article

References (46)

1. Adler, S., Langenmayer, I., Kaspar, M., Christgau, H., Beyer, C., Lang, S., Dengler, R., Emmerich, B. & Straka, C. (1996) High-dose busulfan and cyclophosphamide with autologous peripheral blood progenitor cell transplantation in patients with relapsed lymphoma - efficacy and toxicity. Annals of Oncology, 7s3, 177.
2. Ashihara, E., Shimazaki, C., Yamagata, N., Hirata, T., Okawa, K., Oku, N., Goto, H., Inaba, T., Fujita, N. & Nakagawa, M. (1994) Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis. Bone Marrow Transplantation, 13, 377-381.
3. Bourgault, I., Gomez, A., Gomard, E. & Levy, J.P. (1991) Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. Clinical and Experimental Immunology, 84, 501-507.
4. Burrows, S.R., Gardner, J., Khanna, R., Steward, T., Moss, D.J., Rodda, S.J. & Suhrbier, A. (1994) Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3. Journal of General Virology, 75, 1-5.
5. Chao, N.J., Schriber, J.R., Grimes, K., Long, G.D., Negrin, R.S., Raimondi, C.M., Horning, S.J., Brown, S.L., Miller, L. & Blume, K.G. (1993) Granulocyte colony-stimulating factor 'mobilized' peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood, 81, 2031-2035.
6. Charmot, D., Ragueneau, M., Olive, D., Maraninchi, D. & Mawas, C. (1987) Generation of CD8 cytolytic T cells early after autologous or allogeneic bone marrow transplantation. Bone Marrow Transplantation, 2, 183-194.
7. Crawford, D.H., Edwards, J.B.M., Sweny, P., Janossy, G. & Hoffbrand, A.V. (1981) Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet, 1, 10.
8. Daley, J.P., Rozans, M.K., Smith, B.R., Burakoff, S.J., Rappeport, J.M. & Miller, R.A. (1987) Retarded recovery of functional T cell frequencies in T cell-depleted bone marrow transplant recipients. Blood, 70, 960-964.
9. Falk, C.S., Steinle, A. & Schendel, D.J. (1995) Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells. Journal of Experimental Medicine, 182, 1005-1018.
10. Fegan, C., Thomas, H., Bailey-Wood, R., Coleman, S., Phillips, S., Hoy, T. & Whittaker, J.A. (1995) In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation. Bone Marrow Transplantation, 16, 277-281.
11. Gavioli, R., Kurilla, M.G., Campos-Lima de, P.O., Wallace, L.E., Dolcetti, R., Murray, R.J., Rickinson, A.B. & Masucci, M.G. (1993) Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. Journal of Virology, 67, 1572-1578.
12. Gratama, J.W. (1994) Epstein-Barr virus infections in bone marrow transplantation recipients. In: Bone Marrow Transplantation, Vol. 1. (ed. by S.J. Forman, K.G. Blume & E.D. Thomas), pp. 429-442. Blackwell Sciences, Cambridge, MA.
13. Guillaume, T., Sekhavat, M., Rubinstein, D.B., Hamdan, O., Leblanc, P. & Symann, M.L. (1994) Defective cytokine production following autologous transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution. Cancer Research, 54, 3800-3807.
14. Guillaume, T., Rubinstein, D.B. & Symann, M. (1998) Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood, 92, 1471-1490.
15. Hanto, D.W. (1995) Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: Implications for understanding their pathogenesis and developing rational treatment strategies. Annual Reviews in Medicine, 46, 381-394.
16. Kiesel, S., Pezzutto, A., Körbling, M., Haas, R., Schulz, R., Hunstein, W. & Dörken, B. (1989) Autologous peripheral blood stem cell transplantation: analysis of autografted cells and lymphocyte recovery. Transplantation Proceedings, 21, 3084-3088.
17. Koehne, C., Zeller, W., Stockschlaeder, M. & Zander, A.R. (1997) Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation, 19, 149-156.
18. Ling, N.R. (1973) Immune surveillance of lymphoid tissue. A biological role for the mixed lymphocyte reaction. Immunological Communications, 2, 119-127.
19. Ling, N.R., Hardie, D., Lowe, J., Johnson, G.D., Khan, M. & MacLennan, I.C. (1989) A phenotypic study of cells from Burkitt lymphoma and EBV-B-lymphoblastoid lines and their relationship to cells in normal lymphoid tissues. International Journal of Cancer, 43, 112-118.
20. Lucas, K.G., Small, T.N., Heller, G., Dupont, B. & O'Reilly, R.J. (1996) The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood, 87, 2594-2603.
21. Maudsley, D.J. & Pound, J.D. (1991) Modulation of MHC antigen expression by viruses and oncogenes. Immunology Today, 12, 429-?.
22. Mingari, M.C., Ponte, M., Bertone, S., Schiavetti, F., Vitale, C., Bellomo, R., Moretta, A. & Moretta, L. (1998) HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen-or alloantigen-activated CD8+ T cells. Proceedings of the National Academy of Sciences of the USA, 95, 1172-1177.
23. Mitterer, M., Hirber, J., Gentilini, I., Prinoth, O., Fabris, P., Emmerich, B., Coser, P. & Straka, C. (1996) Target value tailored (TVT) apheresis approach for blood progenitor cell collection after high-dose chemotherapy and rh-G-CSF. Bone Marrow Transplantation, 18, 611-617.
24. Nolte, A., Buhmann, R., Straka, C., Emmerich, B. & Hallek, M. (1998) Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation, 21, 909-916.
25. Nossner, E., Falk, C.S., Jantzer, P., Reinhardt, C., Steinle, A. & Schendel, D.J. (1996) The HLA likes and dislikes of allospecific and non-MHC-restricted cytotoxic T lymphocytes. Immunological Reviews, 154, 105-135.
26. Olsen, G.A., Gockerman, J.P., Bast, R.C., Jr, Borowitz, M. & Peters, W.P. (1988) Altered immunologic reconstitution after standard-dose chemotherapy or high-dose chemotherapy with autologous bone marrow support. Transplantation, 46, 57-60.
27. Rabin, J., Hopkins, R.F., Ruscetti, F.W., Neubauer, R.H., Brown, R.L. & Kawakami, T.G. (1981) Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumour cells. Journal of Immunology, 127, 1852-1856.
28. Reusser, P., Riddell, S.R., Meyers, J.D. & Greenberg, P.D. (1991) Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood, 78, 1373-1380.
29. Reusser, P., Attenhofer, R., Hebart, H., Helg, C., Chapuis, B. & Einsele, H. (1997) Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants. Blood, 89, 3873-3879.
30. Rickinson, A.B., Moss, D.J., Wallace, L.E., Rowe, M., Misko, I.S., Epstein, M.A. & Pope, J.H. (1981) Long-term T-cell-mediated immunity to Epstein-Barr virus. Cancer Research, 41, 4216-4221.
31. Roberts, M.M., To, L.B., Gillis, D., Mundy, J., Rawling, C., Ng, K. & Juttner, C.A. (1993) Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplantation, 12, 469-475.
32. Rozans, M.K., Smith, B.R., Burakoff, S.J. & Miller, R.A. (1986) Long-lasting deficit of functional T cell precursors in human bone marrow transplant recipients revealed by limiting dilution methods. Journal of Immunology, 136, 4040-4048.
33. Scambia, G., Panici, P.B., Pierelli, L., Baiocchi, G., Rumi, C., Menichella, G., Foddai, M.L., Serafini, R., Arno, E., Bonanno, G., Bizzi, B. & Mancuso, S. (1993) Immunological reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation for advanced ovarian cancer. European Journal of Cancer, 29a, 1518-1522.
34. Scheid, C., Pettengell, R., Ghielmini, M., Radford, J.A., Morgenstern, G.R., Stern, P.L. & Crowther, D. (1995) Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma. Bone Marrow Transplantation, 15, 901-906.
35. Schendel, D.J., Oberneder, R., Falk, C.S., Jantzer, P., Kressenstein, S., Maget, B., Hofstetter, A., Riethmuller, G. & Nossner, E. (1997) Cellular and molecular analyses of major histocompatibility complex (MHC) restricted and non-MHC-restricted effector cells recognizing renal cell carcinomas: problems and perspectives for immunotherapy. Journal of Molecular Medicine, 75, 400-413.
36. Schendel, D.J., Wank, R. & Dupont, B. (1979) Standardization of the human in vitro cell-mediated lympholysis technique. Tissue Antigens, 13, 112-120.
37. Schmitz, N. (1997) Rezidivtherapie hochmaligner Non-Hodgkin-Lymphome. Internist, 38, 143-149.
38. Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.H., Boogaerts, M.A., Ferrant, A., Demuynck, H.M.S., Link, H., Zander, A., Barge, A. & Borkett, K. (1996) Randomised trial of filgastrim-mobilized peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet, 347, 353-357.
39. Siegel, S. & Castellani, N.J. (1988) Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, Singapore.
40. Straka, C., Drexler, E., Mitterer, M., Langenmeyer, I., Pfefferkorn, L., Stade, B., Koll, R. & Emmerich, B. (1995) Autotransplantation of B-cell purged peripheral blood progenitor cells in B-cell lymphoma. Lancet, 345, 797-798.
41. Talmadge, J.E., Reed, E., Ino, K., Kessinger, A., Kuszynski, C., Heimann, D., Varney, M., Jackson, J., Vose, J.M. & Bierman, P.J. (1997) Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplantation, 19, 161-172.
42. Talmadge, J.E., Reed, E.C., Kessinger, A., Kuszynski, C.A., Perry, G.A., Gordy, C.L., Mills, K.C., Thomas, M.L., Pirruccello, S.J., Letheby, B.A., Arneson, M.A. & Jackson, J.D. (1996) Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. Bone Marrow Transplantation, 17,101-109.
43. Tilkin, A.-F., Bagot, M., Dreyfus, F., Kayibanda, M., Cordonnier, C., Vernont, J.P. & Levy, J.-P. (1987) Reconstitution of cytotoxic T lymphocyte activity following allogeneic bone marrow transplantation in man. Transplantation, 44, 303-308.
44. To, L.B., Roberts, M.M., Haylock, D.N., Dyson, P.G., Branford, A.L., Thorp, D., Ho, J.Q., Dart, G.W., Horvath, N. & Davy, M.L. (1992) Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplantation, 9, 277-284.
45. Velardi, A., Varese, P., Grossi, E.E., Albi, N., Dembech, C., Terenzi, A., Moretta, L., Grignani, F., Martelli, M.F. & Mingari, M.C. (1990) Cytolytic function of clonable T cells after human bone marrow transplantation. Blood, 75, 1364-1369.
46. Vose, J.M., Anderson, J.R., Kessinger, A., Bierman, P.J., Coccia, P., Reed, E.C., Gordon, B. & Armitage, J.O. (1993) High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology, 11, 1846-1851.